The Role of Nuclease in Biofilm Development and Disease
核酸酶在生物膜发育和疾病中的作用
基本信息
- 批准号:8378720
- 负责人:
- 金额:$ 49.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcute DiseaseAddressAntibioticsApplications GrantsBackBiochemicalCellsChromatinChronic DiseaseCollaborationsCommunitiesCommunity HealthcareCyclic PeptidesCytoplasmic GranulesDNADevelopmentDiseaseEngineeringEquilibriumExposure toExtracellular StructureForeign BodiesGenomeGoalsImmuneInfectionInflammatory ResponseInstructionInvestigationLaboratoriesLifeLife StyleLinkMethodsMicrobeMicrobial BiofilmsModelingMolecularMusPathogenesisPeptide LibraryPeptidesProcessProteinsReportingResistanceRoleSignal TransductionStaphylococcus aureusStreptococcusStructureSurfaceTechnologyTherapeuticVirulence FactorsWorkbasechemotherapycombatextracellularhigh throughput screeninginteininterestkillingsmethicillin resistant Staphylococcus aureusmouse modelmutantneutrophilnew technologynovel strategiesnucleasepathogenquorum sensingresearch studysmall moleculetool
项目摘要
Staphylococcus aureus is emerging as the most problemafic bacterial pathogen facing our community and
healthcare settings. An effective strategy for S. aureus to survive in the host is to attach to a surface and
develop into an encased community of cells called a biofilm. We recenfiy discovered that quorum-sensing
can control the balance between a planktonic or biofilm lifestyle, suggesfing that modulafion of this dispersal
mechanism could be an effective therapeutic strategy. In collaboration with Dr. Kenneth Bayles (the PI of
this PPG), we demonstrated that a deletion of the S. aureus secreted nuclease (Nuc) caused an overall
thickening of the biofilm and inhibited secondary structure formation, and we have confirmed a recent report
that S. aureus possesses a second extracellular nuclease activity (Nuc2). Based on these findings, our
central hypothesis is that control over extracellular nuclease activity is a critical determinant of biofilm
maturafion and dispersal. To address this quesfion, in Specific Aim 1 we will (i) define the role of Nuc and
Nuc2 in biofilm maturation; (ii) determine whether nuclease activity is important for biofilm dispersal; and (iii)
modulate biofilm integrity with controlled exposure to nuclease. We further propose that S. aureus nuclease
is an important virulence factor. To investigate the nuclease funcfion in disease, we will work with Dr.
Tammy Kielian (Project 4 leader) and (i) examine the role of nuclease acfivity in evasion of neutrophil
extracellular traps (NETs); (ii) define the significance of nuclease in mouse models of planktonic versus
biofilm infecfion; and (iii) compare the host inflammatory response to nuclease in planktonic versus biofilm
infection. Finally, we speculate that small-molecule inducers of nuclease activity could serve as anfi-biofilm
therapeufics. Towards this end, in Specific Aim 3, we will employ new technology to generate cyclic peptide
libraries in S. aureus that are amenable to high-throughput screening methods. More specifically, we will (i)
screen for cyclic pepfides that induce nuclease expression through FACS; (ii) perform molecular and
biochemical studies to identify pepfide targets; (iii) characterize the best candidates as dispersal agents in a
biofilm infection model; and (iv) compare results to transposon mutants with increased nuclease activity.
Overall, the goal of this Project is to understand how these S. aureus biofilm structures form and
disassemble, the contribufion of extracellular DNA to this process, and the relevance in disease.
RELEVANCE (See instructions):
金黄色葡萄球菌正在成为我们社区面临的最具问题的细菌病原体,
医疗保健设置。一种有效的S.金黄色葡萄球菌在宿主中存活的方法是附着在表面上,
发展成一个被包围的细胞群落,称为生物膜。我们最近发现群体感应
可以控制一种营养或生物膜生活方式之间的平衡,
机制可能是一种有效的治疗策略。与Kenneth Bayles博士(PI)合作,
这个PPG),我们证明了S.金黄色葡萄球菌分泌的核酸酶(Nuc)引起整体
增厚的生物膜和抑制二级结构的形成,我们已经证实了最近的报告
那辆多金黄色葡萄球菌具有第二胞外核酸酶活性(Nuc 2)。根据这些发现,我们
中心假设是对细胞外核酸酶活性的控制是生物膜的关键决定因素
成熟与扩散为了解决这个问题,在具体目标1中,我们将(i)定义Nuc的作用,
(ii)确定核酸酶活性对于生物膜分散是否重要;和(iii)
通过受控地暴露于核酸酶来调节生物膜完整性。我们进一步提出S.金黄色核酸酶
是重要的毒力因子。为了研究核酸酶在疾病中的作用,我们将与Dr。
Tammy Kielian(项目4负责人)和(i)检查核酸酶活性在中性粒细胞逃避中的作用
细胞外陷阱(NET);(ii)定义核酸酶在小鼠模型中的意义,
生物膜感染;和(iii)比较宿主对促炎性与生物膜中核酸酶的炎症反应
感染最后,我们推测核酸酶活性的小分子诱导物可以作为抗真菌生物膜
治疗学为此,在具体目标3中,我们将采用新技术来生成环肽
图书馆在S。金黄色葡萄球菌,适合于高通量筛选方法。具体而言,我们将(i)
通过FACS筛选诱导核酸酶表达环肽;(ii)进行分子和
生物化学研究,以确定pepfide目标;(iii)表征最佳候选人作为分散剂,
生物膜感染模型;和(iv)将结果与具有增加的核酸酶活性的转座子突变体进行比较。
总的来说,这个项目的目标是了解这些S。金黄色葡萄球菌生物膜结构形成,
分解,细胞外DNA对这一过程的贡献,以及与疾病的相关性。
相关性(参见说明):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH W. BAYLES其他文献
KENNETH W. BAYLES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH W. BAYLES', 18)}}的其他基金
A Bedside-to-Bench Approach to Pandemic Preparedness
流行病防范的从床边到工作台的方法
- 批准号:
10611759 - 财政年份:2022
- 资助金额:
$ 49.4万 - 项目类别:
The molecular control of bacterial programmed cell death
细菌程序性细胞死亡的分子控制
- 批准号:
9901430 - 财政年份:2016
- 资助金额:
$ 49.4万 - 项目类别:
The Role of Nuclease in Biofilm Development and Disease
核酸酶在生物膜发育和疾病中的作用
- 批准号:
8292121 - 财政年份:2011
- 资助金额:
$ 49.4万 - 项目类别:
相似海外基金
Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
- 批准号:
10712647 - 财政年份:2001
- 资助金额:
$ 49.4万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
6247642 - 财政年份:1997
- 资助金额:
$ 49.4万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
3718999 - 财政年份:
- 资助金额:
$ 49.4万 - 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
- 批准号:
465668867 - 财政年份:
- 资助金额:
$ 49.4万 - 项目类别:
Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
- 批准号:
3719026 - 财政年份:
- 资助金额:
$ 49.4万 - 项目类别: